Table 2 Open in new tab Descriptive...

Never started (n = 26 277)

Continuous (n = 7934)

Discontinuous (n = 9107)

Cessation (n = 4109)

Age

≤55

429

188

208

1.63

2.37

2.28

1.58

56–75

6311

3620

4216

1213

24.02

45.63

46.29

29.52

76–85

10 634

3242

3862

1960

40.47

40.86

42.41

47.70

>85

8903

884

821

871

33.88

11.14

9.02

21.20

Mean (SD)

80.72 (9.52)

75.36 (8.6)

74.98 (8.39)

78.59 (8.58)

Sex

Female

15 182

4496

5141

2202

57.78

56.67

56.45

53.59

Male

11 095

3438

3966

1907

42.22

43.33

43.55

46.41

CHA₂DS₂-VASC score

6404

2292

2970

994

24.37

28.89

32.61

24.19

9041

2378

2848

1286

34.41

29.97

31.27

31.30

6066

1684

1822

924

23.08

21.23

20.01

22.49

3135

1035

985

601

11.93

13.05

10.82

14.63

1255

428

373

224

4.78

5.39

4.10

5.45

322

107

100

1.23

1.35

1.10

1.65

0.18

0.13

0.10

0.29

0.03

0.00

HAS-BLED score

121

0.46

0.67

0.76

0.49

4698

1628

1757

789

17.88

20.52

19.29

19.2

10 237

3091

3735

1529

38.96

41.01

37.21

7658

2299

2594

1222

29.14

28.98

28.48

29.74

2899

744

827

476

11.03

9.38

9.08

11.58

≥5

664

119

125

2.53

1.5

1.37

1.78

Grouped Charlson index

10 031

4223

4797

1870

38.17

53.23

52.67

45.51

5407

1660

1985

865

20.58

20.92

21.80

21.05

10 839

2051

2325

1374

41.25

25.85

25.53

33.44

Urban–rurality

1–2 (city)

18 620

5374

6204

2797

70.86

67.73

68.12

68.07

3–6 (towns)

3337

1057

1205

550

12.70

13.32

13.23

13.39

7–8 (rural)

4320

1503

1698

762

16.44

18.94

18.64

18.54

SIMD

6153

1688

1933

857

23.42

21.28

21.23

20.86

6328

1796

2038

996

24.08

22.64

22.38

24.24

5349

1642

1946

911

20.36

20.70

21.37

22.17

4552

1476

1689

708

17.32

18.60

18.55

17.23

3895

1332

1501

637

14.82

16.79

16.48

15.50

Prior stroke

1615

367

346

171

6.15

4.63

3.80

4.16

Previous anti-platelet

15 523

4146

5134

2318

59.07

52.26

56.37

56.41

Frailty score

Low risk <5

7114

4204

4174

1045

27.07

52.99

45.83

25.43

Moderate risk 5–15

10 081

2679

3172

1543

38.36

33.77

34.83

37.55

High risk >15

9082

1051

1761

1521

34.56

13.25

19.34

37.02

Table 2

Open in new tab

Descriptive statistics by anti-coagulation status

		Never started (n = 26 277)	Continuous (n = 7934)	Discontinuous (n = 9107)	Cessation (n = 4109)
Age	≤55	429	188	208	65
	%	1.63	2.37	2.28	1.58
	56–75	6311	3620	4216	1213
	%	24.02	45.63	46.29	29.52
	76–85	10 634	3242	3862	1960
	%	40.47	40.86	42.41	47.70
	>85	8903	884	821	871
	%	33.88	11.14	9.02	21.20
	Mean (SD)	80.72 (9.52)	75.36 (8.6)	74.98 (8.39)	78.59 (8.58)
Sex	Female	15 182	4496	5141	2202
	%	57.78	56.67	56.45	53.59
	Male	11 095	3438	3966	1907
	%	42.22	43.33	43.55	46.41
CHA₂DS₂-VASC score	2	6404	2292	2970	994
	%	24.37	28.89	32.61	24.19
	3	9041	2378	2848	1286
	%	34.41	29.97	31.27	31.30
	4	6066	1684	1822	924
	%	23.08	21.23	20.01	22.49
	5	3135	1035	985	601
	%	11.93	13.05	10.82	14.63
	6	1255	428	373	224
	%	4.78	5.39	4.10	5.45
	7	322	107	100	68
	%	1.23	1.35	1.10	1.65
	8	47	10	9	12
	%	0.18	0.13	0.10	0.29
	9	7	0	0	0
	%	0.03	0.00	0.00	0.00
HAS-BLED score	0	121	53	69	20
	%	0.46	0.67	0.76	0.49
	1	4698	1628	1757	789
	%	17.88	20.52	19.29	19.2
	2	10 237	3091	3735	1529
	%	38.96	38.96	41.01	37.21
	3	7658	2299	2594	1222
	%	29.14	28.98	28.48	29.74
	4	2899	744	827	476
	%	11.03	9.38	9.08	11.58
	≥5	664	119	125	73
	%	2.53	1.5	1.37	1.78
Grouped Charlson index	0	10 031	4223	4797	1870
	%	38.17	53.23	52.67	45.51
	1	5407	1660	1985	865
	%	20.58	20.92	21.80	21.05
	2	10 839	2051	2325	1374
	%	41.25	25.85	25.53	33.44
Urban–rurality	1–2 (city)	18 620	5374	6204	2797
	%	70.86	67.73	68.12	68.07
	3–6 (towns)	3337	1057	1205	550
	%	12.70	13.32	13.23	13.39
	7–8 (rural)	4320	1503	1698	762
	%	16.44	18.94	18.64	18.54
SIMD	1	6153	1688	1933	857
	%	23.42	21.28	21.23	20.86
	2	6328	1796	2038	996
	%	24.08	22.64	22.38	24.24
	3	5349	1642	1946	911
	%	20.36	20.70	21.37	22.17
	4	4552	1476	1689	708
	%	17.32	18.60	18.55	17.23
	5	3895	1332	1501	637
	%	14.82	16.79	16.48	15.50
Prior stroke	%	1615	367	346	171
Prior stroke	%	6.15	4.63	3.80	4.16
Previous anti-platelet	%	15 523	4146	5134	2318
Previous anti-platelet	%	59.07	52.26	56.37	56.41
Frailty score	Low risk <5	7114	4204	4174	1045
	Low risk <5	27.07	52.99	45.83	25.43
	Moderate risk 5–15	10 081	2679	3172	1543
	Moderate risk 5–15	38.36	33.77	34.83	37.55
	High risk >15	9082	1051	1761	1521
	High risk >15	34.56	13.25	19.34	37.02

		Never started (n = 26 277)	Continuous (n = 7934)	Discontinuous (n = 9107)	Cessation (n = 4109)
Age	≤55	429	188	208	65
	%	1.63	2.37	2.28	1.58
	56–75	6311	3620	4216	1213
	%	24.02	45.63	46.29	29.52
	76–85	10 634	3242	3862	1960
	%	40.47	40.86	42.41	47.70
	>85	8903	884	821	871
	%	33.88	11.14	9.02	21.20
	Mean (SD)	80.72 (9.52)	75.36 (8.6)	74.98 (8.39)	78.59 (8.58)
Sex	Female	15 182	4496	5141	2202
	%	57.78	56.67	56.45	53.59
	Male	11 095	3438	3966	1907
	%	42.22	43.33	43.55	46.41
CHA₂DS₂-VASC score	2	6404	2292	2970	994
	%	24.37	28.89	32.61	24.19
	3	9041	2378	2848	1286
	%	34.41	29.97	31.27	31.30
	4	6066	1684	1822	924
	%	23.08	21.23	20.01	22.49
	5	3135	1035	985	601
	%	11.93	13.05	10.82	14.63
	6	1255	428	373	224
	%	4.78	5.39	4.10	5.45
	7	322	107	100	68
	%	1.23	1.35	1.10	1.65
	8	47	10	9	12
	%	0.18	0.13	0.10	0.29
	9	7	0	0	0
	%	0.03	0.00	0.00	0.00
HAS-BLED score	0	121	53	69	20
	%	0.46	0.67	0.76	0.49
	1	4698	1628	1757	789
	%	17.88	20.52	19.29	19.2
	2	10 237	3091	3735	1529
	%	38.96	38.96	41.01	37.21
	3	7658	2299	2594	1222
	%	29.14	28.98	28.48	29.74
	4	2899	744	827	476
	%	11.03	9.38	9.08	11.58
	≥5	664	119	125	73
	%	2.53	1.5	1.37	1.78
Grouped Charlson index	0	10 031	4223	4797	1870
	%	38.17	53.23	52.67	45.51
	1	5407	1660	1985	865
	%	20.58	20.92	21.80	21.05
	2	10 839	2051	2325	1374
	%	41.25	25.85	25.53	33.44
Urban–rurality	1–2 (city)	18 620	5374	6204	2797
	%	70.86	67.73	68.12	68.07
	3–6 (towns)	3337	1057	1205	550
	%	12.70	13.32	13.23	13.39
	7–8 (rural)	4320	1503	1698	762
	%	16.44	18.94	18.64	18.54
SIMD	1	6153	1688	1933	857
	%	23.42	21.28	21.23	20.86
	2	6328	1796	2038	996
	%	24.08	22.64	22.38	24.24
	3	5349	1642	1946	911
	%	20.36	20.70	21.37	22.17
	4	4552	1476	1689	708
	%	17.32	18.60	18.55	17.23
	5	3895	1332	1501	637
	%	14.82	16.79	16.48	15.50
Prior stroke	%	1615	367	346	171
Prior stroke	%	6.15	4.63	3.80	4.16
Previous anti-platelet	%	15 523	4146	5134	2318
Previous anti-platelet	%	59.07	52.26	56.37	56.41
Frailty score	Low risk <5	7114	4204	4174	1045
	Low risk <5	27.07	52.99	45.83	25.43
	Moderate risk 5–15	10 081	2679	3172	1543
	Moderate risk 5–15	38.36	33.77	34.83	37.55
	High risk >15	9082	1051	1761	1521
	High risk >15	34.56	13.25	19.34	37.02

This Feature Is Available To Subscribers Only